The key findings include the following: Hemoglobin levels increased by an average of 3.11 mg/dl after three months of ferrous sulfate treatment. Serum ferritin levels improved by an average of 5.9 ...

Sparsentan (Filspari, Vifor) is indicated for 'the treatment of adults with primary immunoglobulin A nephropathy (IgAN) with a urine protein excretion ≥ 1.0 g/day (or urine protein-to-creatinine ratio ...